Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: updated results of a multicentric trial.
Boccardo F, Barichello M, Battaglia M, Carmignani G, Comeri G, Ferraris V, Lilliu S, Montefiore F, Portoghese F, Cortellini P, Rigatti P, Usai E, Rubagotti A; Italian Prostate Cancer Group. Boccardo F, et al. Among authors: rubagotti a. Eur Urol. 2002 Nov;42(5):481-90. doi: 10.1016/s0302-2838(02)00435-9. Eur Urol. 2002. PMID: 12429158 Clinical Trial.
An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.
Bedognetti D, Rubagotti A, Conti G, Francesca F, De Cobelli O, Canclini L, Gallucci M, Aragona F, Di Tonno P, Cortellini P, Martorana G, Lapini A, Boccardo F. Bedognetti D, et al. Among authors: rubagotti a. Eur Urol. 2010 Feb;57(2):238-45. doi: 10.1016/j.eururo.2009.05.019. Epub 2009 May 19. Eur Urol. 2010. PMID: 19481335 Clinical Trial.
Zoladex with or without flutamide in the treatment of locally advanced or metastatic prostate cancer: interim analysis of an ongoing PONCAP study. Italian Prostatic Cancer Project (PONCAP).
Boccardo F, Decensi A, Guarneri D, Rubagotti A, Oneto F, Martorana G, Giuliani L, Delli Ponti U, Petracco S, Cortellini P, et al. Boccardo F, et al. Among authors: rubagotti a. Eur Urol. 1990;18 Suppl 3:48-53. doi: 10.1159/000463981. Eur Urol. 1990. PMID: 2151277 Clinical Trial.
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.
Boccardo F, Rubagotti A, Barichello M, Battaglia M, Carmignani G, Comeri G, Conti G, Cruciani G, Dammino S, Delliponti U, Ditonno P, Ferraris V, Lilliu S, Montefiore F, Portoghese F, Spano G. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 1999 Jul;17(7):2027-38. doi: 10.1200/JCO.1999.17.7.2027. J Clin Oncol. 1999. PMID: 10561254 Clinical Trial.
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.
Boccardo F, Rubagotti A, Battaglia M, Di Tonno P, Selvaggi FP, Conti G, Comeri G, Bertaccini A, Martorana G, Galassi P, Zattoni F, Macchiarella A, Siragusa A, Muscas G, Durand F, Potenzoni D, Manganelli A, Ferraris V, Montefiore F. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 2005 Feb 1;23(4):808-15. doi: 10.1200/JCO.2005.12.013. J Clin Oncol. 2005. PMID: 15681525 Clinical Trial.
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Boccardo F, Rubagotti A, Conti G, Potenzoni D, Manganelli A, Del Monaco D. Boccardo F, et al. Among authors: rubagotti a. Cancer Chemother Pharmacol. 2005 Oct;56(4):415-20. doi: 10.1007/s00280-005-1016-1. Epub 2005 Apr 19. Cancer Chemother Pharmacol. 2005. PMID: 15838655 Clinical Trial.
Switching to aromatase inhibitors in early breast cancer.
Boccardo F, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Lancet. 2007 Feb 17;369(9561):533-5. doi: 10.1016/S0140-6736(07)60201-3. Lancet. 2007. PMID: 17307082 No abstract available.
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the 'gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)' 01-Trial in early breast cancer.
Boccardo F, Guglielmini P, Parodi A, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Breast Cancer Res Treat. 2011 Apr;126(3):653-61. doi: 10.1007/s10549-011-1405-6. Epub 2011 Feb 24. Breast Cancer Res Treat. 2011. PMID: 21347647 Clinical Trial.
Prognostic value of nuclear matrix protein expression in localized prostate cancer.
Ricci F, Rubagotti A, Zinoli L, Mangerini R, Nuzzo PV, Carmignani G, Simonato A, Barboro P, Balbi C, Boccardo F. Ricci F, et al. Among authors: rubagotti a. J Cancer Res Clin Oncol. 2012 Aug;138(8):1379-84. doi: 10.1007/s00432-012-1216-0. Epub 2012 Apr 10. J Cancer Res Clin Oncol. 2012. PMID: 22488172
121 results